Comparison of 5.0T and 3.0T Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer

Launched by ANHUI PROVINCIAL HOSPITAL · Sep 21, 2024

Keywords

ClinConnect Summary

This clinical trial is studying two different types of MRI scans, called 5.0T and 3.0T biparametric MRI, to see which one is better at diagnosing prostate cancer. The researchers want to find out how accurately each scan can detect prostate cancer and determine how advanced the cancer is. The trial is currently looking for male participants aged 65 to 74 who need a prostate biopsy, have a clear history of prostate cancer, and are willing to undergo both types of MRI scans.

To be eligible for the study, participants must not have any conditions that would prevent them from having an MRI or a biopsy, and they should not have had previous prostate surgery. If you join the study, you can expect to have both the 3.0T and 5.0T MRI scans done, which will help researchers understand how effective these imaging techniques are for diagnosing prostate cancer. Your participation will help improve diagnosis methods for future patients.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • 1. The patient has at least one indication for prostate biopsy (Chinese expert consensus on prostate biopsy (2022 edition) );
• • 2. The primary prostate cancer has no other cancer history;
• • 3. The 3.0TbpMRI examination was completed, and the images were clear and accessible;
• • 4. The 5.0TbpMRI examination was further completed, and the images were clear and accessible;
• • 5. The patient fully understands the relevant content of the study and voluntarily signs the informed consent.
• Exclusion Criteria:
• • 1. The patient has contraindications to MRI examination, such as metal plates and heart stents in the body;
• • 2. The patient does not have an indication for prostate biopsy or refuses biopsy;
• • 3. The patient has contraindications to prostate biopsy;
• • 4. 3.0T MRI considers that the patient has multiple lymph node or bone metastases;
• • 5. The patient has undergone other prostatic surgery in the past;
• • 6. The patient is unable to cooperate, has communication barriers, or refuses to sign the informed consent form.